$BPRN
Princeton Bancorp, Inc. Stock $bprn

$bprn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000119312524076546 Filed on March 25, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$28.07M		$98.18M
YoY Change	36.16%		32.53%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$1.160M		$5.026M
YoY Change	-10.77%		11.99%
% of Gross Profit
Depreciation & Amortization	$530.0K	$530.0K	$1.978M
YoY Change	20.18%	6.85%	-3.61%
% of Gross Profit
Operating Expenses	$1.160M		$5.026M
YoY Change	-10.77%		11.99%
Operating Profit
YoY Change
Interest Expense	$12.62M		$33.16M
YoY Change	219.36%		452.73%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$5.411M	$6.278M	$30.34M
YoY Change	-32.35%	-33.01%	-10.92%
Income Tax	$1.066M	$996.0K	$4.570M
% Of Pretax Income	19.7%	15.86%	15.07%
Net Earnings	$4.345M	$5.282M	$25.77M
YoY Change	-28.74%	-26.34%	-2.75%
Net Earnings / Revenue	15.48%		26.24%
Basic Earnings Per Share	$0.69		$4.10
Diluted Earnings Per Share	$0.68	$0.82	$4.03
COMMON SHARES
Basic Shares Outstanding	6.337M	6.298M	6.281M
Diluted Shares Outstanding	6.418K		6.389K

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$172.1M	$150.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$14.12M	$14.45M	$37.85M
YoY Change	21.03%	23.3%	36.41%
Goodwill	$8.853M	$8.853M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$9.051M	$8.296M	$8.296M
YoY Change		302.52%
Other Assets	$11.61M	$11.51M	$11.51M
YoY Change	49.09%	51.49%	51.49%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.988B	$1.916B	$1.916B
YoY Change	25.4%	19.65%	19.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.83M	$9.162M	$9.162M
YoY Change	447.73%	792.11%	792.11%
Accrued Expenses	$23.64M	$24.28M	$24.28M
YoY Change	43.59%	44.77%	44.77%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$35.47M	$33.44M	$33.44M
YoY Change	90.45%	87.89%	87.89%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.099M	$40.55M	$40.55M
YoY Change	5.77%	65.84%	65.84%
Total Long-Term Liabilities	$5.099M	$40.55M	$40.55M
YoY Change	5.77%	65.84%	65.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.47M	$33.44M	$33.44M
Total Long-Term Liabilities	$5.099M	$40.55M	$40.55M
Total Liabilities	$1.746B	$1.676B	$1.676B
YoY Change	28.39%	21.28%	21.28%
SHAREHOLDERS EQUITY
Retained Earnings	$151.9M	$149.4M
YoY Change	12.14%	13.63%
Common Stock	$98.31M	$98.29M
YoY Change	1.48%	-15.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$241.8M	$240.2M	$240.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.988B	$1.916B	$1.916B
YoY Change	25.4%	19.65%	19.65%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$4.345M	$5.282M	$25.77M
YoY Change	-28.74%	-26.34%	-2.75%
Depreciation, Depletion And Amortization	$530.0K	$530.0K	$1.978M
YoY Change	20.18%	6.85%	-3.61%
Cash From Operating Activities	$4.827M	$2.963M	$23.11M
YoY Change	-32.83%	-61.15%	-3.65%
INVESTING ACTIVITIES
Capital Expenditures	$71.00K	$292.0K	$1.712M
YoY Change	-71.02%	342.42%	182.04%
Acquisitions
YoY Change
Other Investing Activities	-$50.47M	-$55.09M	-$4.048M
YoY Change	157.58%	-721.03%	-84.34%
Cash From Investing Activities	-$50.54M	-$55.38M	-$5.760M
YoY Change	154.76%	-729.0%	-78.23%
FINANCING ACTIVITIES
Cash Dividend Paid	$1.899M		$7.555M
YoY Change	1.23%		17.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	67.22M	-3.960M	79.85M
YoY Change	-396.43%	-64.15%	-177.61%
NET CHANGE
Cash From Operating Activities	4.827M	2.963M	23.11M
Cash From Investing Activities	-50.54M	-55.38M	-5.760M
Cash From Financing Activities	67.22M	-3.960M	79.85M
Net Change In Cash	21.51M	-56.37M	97.21M
YoY Change	-160.89%	-1146.68%	-192.26%
FREE CASH FLOW
Cash From Operating Activities	$4.827M	$2.963M	$23.11M
Capital Expenditures	$71.00K	$292.0K	$1.712M
Free Cash Flow	$4.756M	$2.671M	$21.40M
YoY Change	-31.48%	-64.67%	-8.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001913971
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41589
CY2023	dei	Entity Registrant Name EntityRegistrantName	PRINCETON BANCORP, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8296000
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2061000
CY2023Q4	us-gaap	Other Assets OtherAssets	10259000
CY2022Q4	us-gaap	Other Assets OtherAssets	5778000
CY2023Q4	us-gaap	Assets Assets	1916497000
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-4268702
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	183 Bayard Lane
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Princeton
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08540
CY2023	dei	City Area Code CityAreaCode	609
CY2023	dei	Local Phone Number LocalPhoneNumber	921-1700
CY2023	dei	Security12b Title Security12bTitle	Common stock, no par value
CY2023	dei	Trading Symbol TradingSymbol	BPRN
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	137800000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6337105
CY2023Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	17156000
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	12161000
CY2023Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	17376000
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	13140000
CY2023Q4	us-gaap	Federal Funds Sold FederalFundsSold	116025000
CY2022Q4	us-gaap	Federal Funds Sold FederalFundsSold	28050000
CY2023Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	150557000
CY2022Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	53351000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	91352000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	81341000
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	192000
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	200000
CY2023Q4	us-gaap	Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	193000
CY2022Q4	us-gaap	Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	201000
CY2023Q4	bprn	Loans Receivable Including Deferred Fees And Cost LoansReceivableIncludingDeferredFeesAndCost	1548335000
CY2022Q4	bprn	Loans Receivable Including Deferred Fees And Cost LoansReceivableIncludingDeferredFeesAndCost	1370368000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	18492000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16461000
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1529843000
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1353907000
CY2023Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	58860000
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	52617000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14453000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11722000
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	6089000
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	4756000
CY2023Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	1410000
CY2022Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	1742000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11512000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7599000
CY2023Q4	us-gaap	Goodwill Goodwill	8853000
CY2022Q4	us-gaap	Goodwill Goodwill	8853000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1422000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1825000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23398000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16026000
CY2022Q4	us-gaap	Assets Assets	1601779000
CY2023Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	249282000
CY2022Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	265078000
CY2023Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1386459000
CY2022Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1082652000
CY2023Q4	us-gaap	Deposits Deposits	1635741000
CY2022Q4	us-gaap	Deposits Deposits	1347730000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	0
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	10000000
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	9162000
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1027000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	24280000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16772000
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	7103000
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	6649000
CY2023Q4	us-gaap	Liabilities Liabilities	1676286000
CY2022Q4	us-gaap	Liabilities Liabilities	1382178000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6299331
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6299331
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	5
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6909402
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6245597
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	34547000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	98291000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	81291000
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	663805
CY2023Q4	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	0
CY2022Q4	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	19452000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	149414000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	131488000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7494000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8273000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	240211000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	219601000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1916497000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1601779000
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	89278000
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	70996000
CY2023	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1339000
CY2022	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	986000
CY2023	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1138000
CY2022	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1167000
CY2023	us-gaap	Interest And Dividend Income Securities Held To Maturity InterestAndDividendIncomeSecuritiesHeldToMaturity	10000
CY2022	us-gaap	Interest And Dividend Income Securities Held To Maturity InterestAndDividendIncomeSecuritiesHeldToMaturity	11000
CY2023	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	6415000
CY2022	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	923000
CY2023	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	98180000
CY2022	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	74083000
CY2023	us-gaap	Interest Expense Deposits InterestExpenseDeposits	33046000
CY2022	us-gaap	Interest Expense Deposits InterestExpenseDeposits	5995000
CY2023	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	118000
CY2022	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	5000
CY2023	us-gaap	Interest Expense InterestExpense	33164000
CY2022	us-gaap	Interest Expense InterestExpense	6000000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	65016000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	68083000
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3108000
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	400000
CY2023	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	61908000
CY2022	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	67683000
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	39000
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	2000
CY2023	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	1293000
CY2022	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	1138000
CY2023	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	1853000
CY2022	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	1852000
CY2023	bprn	Loan Fees Including Prepayment Penalties LoanFeesIncludingPrepaymentPenalties	3221000
CY2022	bprn	Loan Fees Including Prepayment Penalties LoanFeesIncludingPrepaymentPenalties	1484000
CY2023	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	9696000
CY2022	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0
CY2023	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	203000
CY2023	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	816000
CY2022	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	386000
CY2023	us-gaap	Noninterest Income NoninterestIncome	17121000
CY2022	us-gaap	Noninterest Income NoninterestIncome	4862000
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	23386000
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	20455000
CY2023	us-gaap	Occupancy Net OccupancyNet	7037000
CY2022	us-gaap	Occupancy Net OccupancyNet	5859000
CY2023	us-gaap	Professional Fees ProfessionalFees	2060000
CY2022	us-gaap	Professional Fees ProfessionalFees	2470000
CY2023	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	5026000
CY2022	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	4488000
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	891000
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1010000
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	504000
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	484000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	508000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	239000
CY2023	us-gaap	Other Expense From Real Estate Partnership Operations OtherExpenseFromRealEstatePartnershipOperations	1000
CY2022	us-gaap	Other Expense From Real Estate Partnership Operations OtherExpenseFromRealEstatePartnershipOperations	106000
CY2023	bprn	Core Deposit Intangible CoreDepositIntangible	502000
CY2022	bprn	Core Deposit Intangible CoreDepositIntangible	569000
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5635000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0
CY2023	us-gaap	Other Noninterest Expense OtherNoninterestExpense	3144000
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2812000
CY2023	us-gaap	Noninterest Expense NoninterestExpense	48694000
CY2022	us-gaap	Noninterest Expense NoninterestExpense	38492000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	30335000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	34053000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4570000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7559000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	44000
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-26000
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-49000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	25765000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	26494000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.1
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.19
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.11
CY2023	us-gaap	Net Income Loss NetIncomeLoss	25765000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	26494000
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1651000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-12723000
CY2023	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	39000
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	2000
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	1612000
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-12725000
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	833000
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-3613000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	779000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9112000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26544000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17382000
CY2023	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	13000000
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	0
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	216578000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	26494000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9112000
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	76900
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1171000
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	8741
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	209000
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	6363000
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	324017
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9420000
CY2022	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	3343
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	219601000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	219601000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	25765000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	779000
CY2023	bprn	Adjustments To Adoption Of Current Expected Credit Losses AdjustmentsToAdoptionOfCurrentExpectedCreditLosses	-284000
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	50900
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	989000
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.2
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	7446000
CY2023	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	3933
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	807000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	240211000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	25765000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	26494000
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3108000
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	400000
CY2023	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	1476000
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	1483000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	807000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	109000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	94000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9420000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	989000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1092000
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	209000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	79854000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-102895000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	97206000
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	2814000
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	5094000
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	39000
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	2000
CY2023	bprn	Increase In Cash Surrender Value Of Bank Owned Life Insurance IncreaseInCashSurrenderValueOfBankOwnedLifeInsurance	1293000
CY2022	bprn	Increase In Cash Surrender Value Of Bank Owned Life Insurance IncreaseInCashSurrenderValueOfBankOwnedLifeInsurance	1138000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	200000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	527000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	502000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	568000
CY2023	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	9696000
CY2022	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0
CY2023	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	203000
CY2022	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-125000
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	101000
CY2023	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-1817000
CY2022	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-943000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3456000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-513000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23112000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23987000
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	8439000
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5377000
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4901000
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	6701000
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1604000
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3659000
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	8000
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	8000
CY2023	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-10738000
CY2022	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	30444000
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	25414000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	23181000
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1712000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	607000
CY2023	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	4950000
CY2022	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6245000
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0
CY2023	us-gaap	Payments For Proceeds From Federal Reserve Bank Stock PaymentsForProceedsFromFederalReserveBankStock	-332000
CY2022	us-gaap	Payments For Proceeds From Federal Reserve Bank Stock PaymentsForProceedsFromFederalReserveBankStock	397000
CY2023	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	236000
CY2022	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5760000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26457000
CY2023	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	96311000
CY2022	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-98413000
CY2023	bprn	Repayment Of Overnight Borrowings RepaymentOfOvernightBorrowings	10000000
CY2022	bprn	Repayment Of Overnight Borrowings RepaymentOfOvernightBorrowings	-10000000
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	7555000
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	6457000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-105365000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53351000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158716000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150557000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53351000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	25029000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	6017000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5883000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6985000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	239451000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
CY2023	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	204341000
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	129
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6389
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6449
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.03
CY2022	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2007-03-05
CY2023	us-gaap	Year Founded YearFounded	2007
CY2023	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	2007-04-23
CY2007Q2	bprn	Number Of Branches Owned By The Entity NumberOfBranchesOwnedByTheEntity	29
CY2023	bprn	Number Of Employees NumberOfEmployees	209
CY2023	bprn	Number Of Full Time Employees NumberOfFullTimeEmployees	206
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";"><div style="font-weight:bold;display:inline;">Estimates </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Because of uncertainties associated with estimating the amounts, timing and likelihood of possible outcomes, actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, the valuation of net assets acquired in business combinations and evaluation of the potential impairment of goodwill. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Management believes that the allowance for credit losses is adequate as of December 31, 2023 and 2022. While management uses current information to recognize losses on loans, future additions to the allowance for loan losses may be necessary based on changes in economic conditions in the market area or other factors. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, various regulatory agencies, as an integral part of their examination process, periodically review the Company’s allowance for credit losses. Such agencies may require the Company to effect certain changes that result in addition to the allowance based on their judgments about information available to them at the time of their examinations. </div>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";"><div style="font-weight:bold;display:inline;">Significant group concentrations of credit risk </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Most of the Company’s activities are with customers located within Mercer County, New Jersey, and surrounding areas as well as the five boroughs of New York City and certain Philadelphia, Pennsylvania metropolitan areas. The Company does not have any portion of its business dependent on a single or limited number of customers or industries, the loss of which would have a material adverse effect on its business. No substantial portion of loans is concentrated within a single industry or group of related industries, except that a significant majority of commercial loans are secured by real estate. There are numerous risks associated with commercial and consumer lending that could impact the borrowers’ ability to repay on a timely basis. They include but are not limited to: the owner’s business expertise, changes in local, national, and in some cases international economies, competition, governmental regulation, and the general financial stability of the borrowing entity. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div>
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.11
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for credit losses - loans </div></div></div></div> <div style="null;text-indent: 0px;;font-weight:bold;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company adopted ASC 326 using the modified retrospective method for all financial assets measured at amortized costs and off-balance sheet credit exposures. Results for reporting periods beginning January 1, 2023 are presented under ASC 326 while prior periods continue to be reported in accordance with previous applicable GAAP. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The credit loss estimation process involves procedures to appropriately consider the unique characteristics of loan portfolio segments, which consist of commercial real estate loans, construction loans, commercial and industrial loans, residential loans and consumer/HELOC loans. These segments are further disaggregated into loan classes, the level at which credit risk is monitored. For each of these segments, the Company generates cash flow projections at the instrument level wherein payment expectations are adjusted for estimated prepayment speed, curtailments, time to recovery, probability of default and loss given default. The modeling of expected prepayment speeds, curtailment rates, and time to recovery are based on historical data. The quantitative component of the ACL on loans is model-based and utilizes a forward-looking macroeconomic forecast. The Company uses a discounted cash flow method, incorporating probability of default and loss given default forecasted based on statistically derived economic variable loss drivers, to estimate expected credit losses. This process includes estimates which involve modeling loss projections attributed to existing loan balances, and considering historical experience, current conditions, and future expectations for segments of loans over a reasonable and supportable forecast period. The historical information used is that experienced by the Company or by a selection of peer banks, when appropriate. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Commercial real estate - </div></div>Loans in this segment include owner-occupied commercial real estate, non-owner occupied commercial real estate and multi-family dwellings within the Company’s market area. The underlying cash flows generated by the properties or operations can be adversely impacted by a downturn in the economy due to increased vacancy rates or diminished cash flows, which in turn, would have an effect on the credit quality in this segment. Management obtains financial information annually and monitors the cash flow of these loans. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Construction</div></div> – Loans in this segment include primarily construction of condominium projects or single-family homes and subdivisions. Exposure to loans in this segment can come from construction delays, slow unit sales and insufficient interest reserves. The Company often requires personal and corporate guarantees as additional security on the loan. Management relies on progress reports and third-party experts prior to the release of </div><div style="font-size: 10pt; font-family: "Times New Roman", serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">additional</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> funds. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Commercial and industrial loans</div></div> - Loans in this segment are primarily for commercial business assets and/or purposes, which usually carry a personal guarantee from the business owners. Repayment is expected from the cash flow of the business. A weakened economy, and resultant decrease in consumer spending, will have an effect on quality in this segment. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Residential real estate loans</div></div> – This portfolio segment consists of first lien mortgages secured by one-to-four family residential properties. The overall health of the economy, including unemployment rates and housing pricing, will have an effect on the credit quality in this segment. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consumer</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">/HELOC </div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">loans</div></div> – Loans in this segment are secured and repayment is dependent on the credit quality of the individual borrower and includes junior-lien mortgages. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Credits with Similar Risk Characteristics.</div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is using Discounted Cash Flow Method (“DCF”) in estimating the component of the allowance for credit losses for loans that share similar risk characteristics with other loans, such loans are segregated into loan segments. The model calculates an expected loss percentage for each segment by considering the probability of default, using life-of-loan analysis periods for all segments, and the historical severity of loss, based on the aggregate net lifetime losses incurred per loan segment. The default and severity factors used to calculate the allowance for credit losses for loans that share similar risk characteristics with other loans are adjusted for differences between historical period used to calculate historical severity of loss, based on the aggregate net lifetime losses incurred per loan segment. The default and severity factors used calculate the allowance for credit losses for loans that share similar risk characteristics with other loans adjusted for differences between the historical loss and severity rates and expected conditions over the remaining lives of the loans in the portfolio related to: a) lending policy and procedures; b) economic conditions; c) volume of the loan portfolio; d) experience and depth of lending management; e) level of delinquencies; f) quality of our loan review system; g) the value of underlying collateral for collateralized loans and h) level of concentration of a particular segment. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Individually Evaluated Financial Assets.</div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For a loan that does not share risk characteristics with other loans, expected credit loss is measured based on net realizable value. For these loans, we recognize expected credit loss equal to the amount by which the net realizable value of the loan is less than the amortized cost basis of the loan, except when the loan is collateral dependent, that is, when the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the sale of the collateral. In these cases, expected credit loss is measured as the difference between amortized cost basis and the loan and the fair value of the collateral less disposal costs (such as sales costs, transfer taxes and unpaid real estate taxes). </div></div></div> <div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for Credit Losses on Off-Balance Sheet Credit Exposures, Including Unfunded Loan Commitments.</div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company maintains a separate allowance for credit losses from off-balance-sheet credit exposures, including unfunded loan commitments, which are included in other liabilities on the consolidated statements of condition. Management estimates the amount of expected losses by calculating a commitment usage factor over the contractual period of exposure that are not unconditionally cancellable by the Company by applying the loss factors used in the ACL methodology to the result of the usage calculation to estimate the liability for credit losses related to unfunded commitments for each loan type. The allowance for credit losses on off-balance sheet credit exposures is adjusted as credit loss expense. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Nonaccrual loans are restored to accrual status if principal and interest payments, under the modified terms, are current for six consecutive months after modification and continued repayment is reasonably assured.</div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Credit quality risk ratings include regulatory classifications of special mention, substandard, doubtful and loss. Loans classified special mention have potential weaknesses that deserve management’s close attention. If uncorrected, the potential weaknesses may result in deterioration of the repayment prospects. Loans rated special mention are starting to show signs of potential weakness and are being closely monitored by management. Loans classified substandard have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They include loans that are inadequately protected by the current sound net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans classified doubtful have all the weaknesses inherent in loans classified substandard with the added characteristic that collection or liquidation in full, on the basis of current conditions and facts, is highly improbable. Loans classified loss are considered uncollectible and are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">charged-off</div> to the allowance for loan losses. Loans not classified are rated pass. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Based on management’s comprehensive analysis of the loan portfolio, management believes the allowance for credit losses is adequate at the reported dates. </div></div></div>
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	241000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	207000
CY2023	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	331000
CY2022	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	331000
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassifications of Prior Year Presentation </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of the prior year. </div></div>
CY2023Q2	bprn	Business Combination Acquired Receivable Allowance For Credit Loss BusinessCombinationAcquiredReceivableAllowanceForCreditLoss	2300000
CY2023	bprn	Valuation Adjustment Of Time Deposits ValuationAdjustmentOfTimeDeposits	407000
CY2023Q4	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P5Y
CY2023	us-gaap	Net Income Loss NetIncomeLoss	25765000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	26494000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6281000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6320000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.1
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.19
CY2023	us-gaap	Net Income Loss NetIncomeLoss	25765000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	26494000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6281000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6320000
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	108
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	101335000
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	233000
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	10216000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	91352000
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	92936000
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	10000
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	11605000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	81341000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	8698000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	117000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	67335000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	10099000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	76033000
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	10216000
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	52026000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	5235000
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	25574000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	6370000
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	77600000
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	11605000
CY2023Q4	bprn	Accrued Interest Income Receivable On Investment AccruedInterestIncomeReceivableOnInvestment	523000
CY2022Q4	bprn	Accrued Interest Income Receivable On Investment AccruedInterestIncomeReceivableOnInvestment	487000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	188
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	10200000
CY2023Q4	bprn	Debt Securities Available For Sale Unrealized Losses Percentage Of Amortized Cost Basis Twelve Months Or Longer DebtSecuritiesAvailableForSaleUnrealizedLossesPercentageOfAmortizedCostBasisTwelveMonthsOrLonger	0.1184
CY2023	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2023	us-gaap	Availableforsale Securities Sold At Par AvailableforsaleSecuritiesSoldAtPar	0
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1600000
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	39000
CY2022	us-gaap	Availableforsale Securities Sold At Par AvailableforsaleSecuritiesSoldAtPar	0
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3700000
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	2000
CY2023Q4	us-gaap	Deposit Liabilities Collateral Issued Financial Instruments DepositLiabilitiesCollateralIssuedFinancialInstruments	0
CY2022Q4	us-gaap	Deposit Liabilities Collateral Issued Financial Instruments DepositLiabilitiesCollateralIssuedFinancialInstruments	0
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1550133000
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1372824000
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	-1798000
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	-2456000
CY2023Q4	bprn	Loans Receivable Including Deferred Fees And Cost LoansReceivableIncludingDeferredFeesAndCost	1548335000
CY2022Q4	bprn	Loans Receivable Including Deferred Fees And Cost LoansReceivableIncludingDeferredFeesAndCost	1370368000
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	18492000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16461000
CY2023Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	589000
CY2022Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	332000
CY2023Q4	bprn	Financing Receivable Allowance For Credit Loss And Off Balance Sheet FinancingReceivableAllowanceForCreditLossAndOffBalanceSheet	19081000
CY2022Q4	bprn	Financing Receivable Allowance For Credit Loss And Off Balance Sheet FinancingReceivableAllowanceForCreditLossAndOffBalanceSheet	16793000
CY2023Q2	us-gaap	Financing Receivable Purchased With Credit Deterioration Amount At Purchase Price FinancingReceivablePurchasedWithCreditDeteriorationAmountAtPurchasePrice	36729000
CY2023Q2	us-gaap	Financing Receivable Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivablePurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	601000
CY2023Q2	us-gaap	Financing Receivable Purchased With Credit Deterioration Discount Premium FinancingReceivablePurchasedWithCreditDeteriorationDiscountPremium	-1202000
CY2023Q2	us-gaap	Financing Receivable Purchased With Credit Deterioration Amount At Par Value FinancingReceivablePurchasedWithCreditDeteriorationAmountAtParValue	37330000
CY2022Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	12377000
CY2022Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1360447000
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1372824000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	118000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	16343000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16461000
CY2023Q4	bprn	Financing Receivable Nonaccrual With Allowance For Credit Loss FinancingReceivableNonaccrualWithAllowanceForCreditLoss	0
CY2023Q4	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	6708000
CY2022Q4	bprn	Financing Receivable Nonaccrual With Allowance For Credit Loss FinancingReceivableNonaccrualWithAllowanceForCreditLoss	148000
CY2022Q4	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	118000
CY2023Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	1542934000
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1550133000
CY2023Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0
CY2022Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	1364634000
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1372824000
CY2022Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	184000
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1372824000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16461000
CY2023	bprn	Financing Receivable Allowance For Credit Losses Current Expected Credit Loss Adoption FinancingReceivableAllowanceForCreditLossesCurrentExpectedCreditLossAdoption	-301000
CY2023	us-gaap	Financing Receivable Allowance For Credit Loss Loan Purchased FinancingReceivableAllowanceForCreditLossLoanPurchased	1707000
CY2023	us-gaap	Financing Receivable Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivablePurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	601000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	1831000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1923000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	116000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	18492000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	0
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	18492000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	18492000
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3100000
CY2023	bprn	Financing Receivable Not Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivableNotPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	1700000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	1800000
CY2023	bprn	Increase Decrease In Reserve For Unfunded Liabilities IncreaseDecreaseInReserveForUnfundedLiabilities	430000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16620000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	400000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	857000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	298000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16461000
CY2023	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	9
CY2023Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	6700000
CY2023Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	4600000
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	4900000
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	4861000
CY2021Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	5639000
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	260000
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	778000
CY2023Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	4601000
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	4861000
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	17405000
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	13409000
CY2021	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	10698000
CY2021	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	686000
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	278000
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	278000
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	196000
CY2021	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	359000
CY2021	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	0
CY2021Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	17683000
CY2021Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	13687000
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	196000
CY2021	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	11057000
CY2021	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	686000
CY2023Q4	bprn	Percentage Of Deposit Liabilities PercentageOfDepositLiabilities	1
CY2022Q4	us-gaap	Deposits Deposits	1347730000
CY2022Q4	bprn	Percentage Of Deposit Liabilities PercentageOfDepositLiabilities	1
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	19000000
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	11600000
CY2022Q4	bprn	Brokers Deposit Liabilities BrokersDepositLiabilities	107400000
CY2023Q4	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	15800000
CY2022Q4	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	3700000
CY2023Q4	bprn	Brokers Deposit Liabilities BrokersDepositLiabilities	87200000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21387000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17179000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6934000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5457000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14453000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11722000
CY2023Q4	bprn	Demand Non Interest Bearing Checking DemandNonInterestBearingChecking	249282000
CY2023Q4	bprn	Percentage Of Non Interest Bearing Deposit Liabilities PercentageOfNonInterestBearingDepositLiabilities	0.1524
CY2022Q4	bprn	Demand Non Interest Bearing Checking DemandNonInterestBearingChecking	265078000
CY2022Q4	bprn	Percentage Of Non Interest Bearing Deposit Liabilities PercentageOfNonInterestBearingDepositLiabilities	0.1967
CY2023Q4	bprn	Demand Interest Bearing Checking DemandInterestBearingChecking	247939000
CY2023Q4	bprn	Percentage Of Interest Bearing Deposit Liabilities PercentageOfInterestBearingDepositLiabilities	0.1516
CY2022Q4	bprn	Demand Interest Bearing Checking DemandInterestBearingChecking	269737000
CY2022Q4	bprn	Percentage Of Interest Bearing Deposit Liabilities PercentageOfInterestBearingDepositLiabilities	0.2001
CY2023Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	146484000
CY2023Q4	bprn	Percentage Of Deposits Savings Deposits PercentageOfDepositsSavingsDeposits	0.0896
CY2022Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	190686000
CY2022Q4	bprn	Percentage Of Deposits Savings Deposits PercentageOfDepositsSavingsDeposits	0.1415
CY2023Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	354005000
CY2023Q4	bprn	Percentage Of Deposits Money Market Deposits PercentageOfDepositsMoneyMarketDeposits	0.2164
CY2022Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	283652000
CY2022Q4	bprn	Percentage Of Deposits Money Market Deposits PercentageOfDepositsMoneyMarketDeposits	0.2105
CY2023Q4	bprn	Time Deposits250000 Or More TimeDeposits250000OrMore	173614000
CY2023Q4	bprn	Percentage Of Time Deposits250000 Or More PercentageOfTimeDeposits250000OrMore	0.1061
CY2022Q4	bprn	Time Deposits250000 Or More TimeDeposits250000OrMore	83410000
CY2022Q4	bprn	Percentage Of Time Deposits250000 Or More PercentageOfTimeDeposits250000OrMore	0.0619
CY2023Q4	bprn	Time Deposits Other TimeDepositsOther	464417000
CY2023Q4	bprn	Percentage Of Time Deposits Other PercentageOfTimeDepositsOther	0.2839
CY2022Q4	bprn	Time Deposits Other TimeDepositsOther	255167000
CY2022Q4	bprn	Percentage Of Time Deposits Other PercentageOfTimeDepositsOther	0.1893
CY2023Q4	us-gaap	Deposits Deposits	1635741000
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	80000
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	81000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10000000
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0461
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Asset FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset	133828000
CY2022Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Asset FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset	189511000
CY2023Q4	bprn	Outstanding Fund Commitment OutstandingFundCommitment	6000000
CY2023Q4	us-gaap	Other Commitment OtherCommitment	5900000
CY2023Q4	bprn	Unfunded Commitment UnfundedCommitment	100000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2943000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4621000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1427000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2411000
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	4370000
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	7032000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	341000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	876000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-141000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-349000
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	200000
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	527000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4570000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7559000
CY2023Q4	bprn	Allowance For Loan Losses AllowanceForLoanLosses	-5252000
CY2022Q4	bprn	Allowance For Loan Losses AllowanceForLoanLosses	-4638000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2406000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	374000
CY2023Q4	bprn	Deferred Tax Assets Branch Acquisition DeferredTaxAssetsBranchAcquisition	0
CY2022Q4	bprn	Deferred Tax Assets Branch Acquisition DeferredTaxAssetsBranchAcquisition	26000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1383000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	681000
CY2023Q4	bprn	Deferred Tax Assets Core Deposit Intangible DeferredTaxAssetsCoreDepositIntangible	460000
CY2022Q4	bprn	Deferred Tax Assets Core Deposit Intangible DeferredTaxAssetsCoreDepositIntangible	397000
CY2023Q4	bprn	Deferred Tax Assets Acquisition Accounting Adjustments DeferredTaxAssetsAcquisitionAccountingAdjustments	1966000
CY2022Q4	bprn	Deferred Tax Assets Acquisition Accounting Adjustments DeferredTaxAssetsAcquisitionAccountingAdjustments	0
CY2023Q4	bprn	Deferred Tax Assets Deferred Ppp Loans DeferredTaxAssetsDeferredPPPLoans	0
CY2022Q4	bprn	Deferred Tax Assets Deferred Ppp Loans DeferredTaxAssetsDeferredPPPLoans	28000
CY2023Q4	bprn	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	6895000
CY2022Q4	bprn	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	4726000
CY2023Q4	bprn	Deferred Tax Assets Serp Liabiltiy DeferredTaxAssetsSERPLiabiltiy	307000
CY2022Q4	bprn	Deferred Tax Assets Serp Liabiltiy DeferredTaxAssetsSERPLiabiltiy	202000
CY2023Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	3007000
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	3322000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21676000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14394000
CY2023Q4	bprn	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	1455000
CY2022Q4	bprn	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	1341000
CY2023Q4	bprn	Deferred Tax Liabilities Deferred Loan Costs DeferredTaxLiabilitiesDeferredLoanCosts	853000
CY2022Q4	bprn	Deferred Tax Liabilities Deferred Loan Costs DeferredTaxLiabilitiesDeferredLoanCosts	335000
CY2023Q4	bprn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	6645000
CY2022Q4	bprn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	4515000
CY2023Q4	bprn	Deferred Tax Liabilities Acquisition Accounting Adjustments DeferredTaxLiabilitiesAcquisitionAccountingAdjustments	0
CY2022Q4	bprn	Deferred Tax Liabilities Acquisition Accounting Adjustments DeferredTaxLiabilitiesAcquisitionAccountingAdjustments	8000
CY2023Q4	bprn	Deferred Tax Liabilities Goodwill Amortization DeferredTaxLiabilitiesGoodwillAmortization	768000
CY2022Q4	bprn	Deferred Tax Liabilities Goodwill Amortization DeferredTaxLiabilitiesGoodwillAmortization	596000
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	443000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10164000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6795000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11512000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7599000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	6370000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	7151000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1016000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.034
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1629000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.048
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	413000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.014
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	772000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.023
CY2023	bprn	Income Tax Reconciliation Income From Owned Life Insurance IncomeTaxReconciliationIncomeFromOwnedLifeInsurance	-272000
CY2023	bprn	Income Tax Reconciliation Income From Owned Life Insurance Percent IncomeTaxReconciliationIncomeFromOwnedLifeInsurancePercent	-0.009
CY2022	bprn	Income Tax Reconciliation Income From Owned Life Insurance IncomeTaxReconciliationIncomeFromOwnedLifeInsurance	0
CY2022	bprn	Income Tax Reconciliation Income From Owned Life Insurance Percent IncomeTaxReconciliationIncomeFromOwnedLifeInsurancePercent	0
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-146000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.004
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	107000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.004
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	17000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.001
CY2023	bprn	Income Tax Reconciliation Internal Revenue Service Refund IncomeTaxReconciliationInternalRevenueServiceRefund	0
CY2023	bprn	Effectiveincometaxratenternal Revenue Service Refund EffectiveincometaxratenternalRevenueServiceRefund	0
CY2022	bprn	Income Tax Reconciliation Internal Revenue Service Refund IncomeTaxReconciliationInternalRevenueServiceRefund	-516000
CY2022	bprn	Effectiveincometaxratenternal Revenue Service Refund EffectiveincometaxratenternalRevenueServiceRefund	-0.015
CY2023	bprn	Income Tax Reconciliation Bargain Purchase Gain IncomeTaxReconciliationBargainPurchaseGain	-2036000
CY2023	bprn	Income Tax Reconciliation Bargain Purchase Gain Percent IncomeTaxReconciliationBargainPurchaseGainPercent	-0.067
CY2022	bprn	Income Tax Reconciliation Bargain Purchase Gain IncomeTaxReconciliationBargainPurchaseGain	0
CY2022	bprn	Income Tax Reconciliation Bargain Purchase Gain Percent IncomeTaxReconciliationBargainPurchaseGainPercent	0
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-202000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.007
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	196000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.005
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4570000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.151
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7559000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.222
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3800000
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1800000
CY2023Q4	bprn	Operatinglosscarryforwardslimitations Operatinglosscarryforwardslimitations	222000
CY2023Q4	bprn	Estimated Utilization Of Operation Loss Carry Forwards EstimatedUtilizationOfOperationLossCarryForwards	2000000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2627000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2487000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	16312000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	30603000
CY2023Q4	bprn	Gross Carrying Amount Operating Lease Right Of Use Asset GrossCarryingAmountOperatingLeaseRightOfUseAsset	16026000
CY2022Q4	bprn	Gross Carrying Amount Operating Lease Right Of Use Asset GrossCarryingAmountOperatingLeaseRightOfUseAsset	17919000
CY2023Q4	bprn	New Lease Operating Lease Right Of Use Asset NewLeaseOperatingLeaseRightOfUseAsset	9799000
CY2023Q4	bprn	Accumulated Amortization Operating Lease Right Of Use Asset AccumulatedAmortizationOperatingLeaseRightOfUseAsset	2427000
CY2022Q4	bprn	Accumulated Amortization Operating Lease Right Of Use Asset AccumulatedAmortizationOperatingLeaseRightOfUseAsset	1893000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23398000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16026000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	24280000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16772000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y10D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0335
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	3772000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2700000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	105000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	94000
CY2023	us-gaap	Lease Cost LeaseCost	3877000
CY2022	us-gaap	Lease Cost LeaseCost	2794000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	3074000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2309000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3162000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3101000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2914000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6323000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	24280000
CY2023	bprn	Base Rental Payments BaseRentalPayments	315000
CY2022	bprn	Base Rental Payments BaseRentalPayments	305000
CY2023Q4	us-gaap	Goodwill Goodwill	8900000
CY2023Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	8900000
CY2023	bprn	Goodwill Amortization Period GoodwillAmortizationPeriod	P15Y
CY2022Q4	us-gaap	Goodwill Goodwill	8853000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1825000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	99000
CY2023	bprn	Amortization Expense AmortizationExpense	502000
CY2023Q4	us-gaap	Goodwill Goodwill	8853000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1422000
CY2021Q4	us-gaap	Goodwill Goodwill	8853000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2393000
CY2022	bprn	Amortization Expense AmortizationExpense	568000
CY2022Q4	us-gaap	Goodwill Goodwill	8853000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1825000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	432000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	353000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	274000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	195000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	116000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	52000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1422000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	330650
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.45
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M13D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3463695000
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	753000
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y8M15D
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	0
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	0
CY2023Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	150557000
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	91352000
CY2023Q4	us-gaap	Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	193000
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1529843000
CY2023Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	1410000
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	6089000
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8296000
CY2023Q4	bprn	Mortgage Servicing Rights At Carrying Value MortgageServicingRightsAtCarryingValue	1562000
CY2023Q4	us-gaap	Deposits Deposits	1635741000
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	9162000
CY2022Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	53351000
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	81341000
CY2022Q4	us-gaap	Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	201000
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1353907000
CY2022Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	1742000
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	4756000
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2061000
CY2022Q4	us-gaap	Deposits Deposits	1347730000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	10000000
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1027000
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	330650
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.45
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	50900
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	13.87
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	279750
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.83
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y3M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3654453000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	279750
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.83
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y3M
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3654453000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	407650
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.08
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	76900
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.18
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	100
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	13.75
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	330650
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.45
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M13D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3463695
CY2023Q4	us-gaap	Banking Regulation Common Equity Tier One Risk Based Capital Ratio Capital Adequacy Minimum BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioCapitalAdequacyMinimum	0.045
CY2023Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.03
CY2023Q4	us-gaap	Banking Regulation Leverage Buffer Minimum BankingRegulationLeverageBufferMinimum	0.04
CY2023Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.06
CY2023Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.08
CY2023Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.08
CY2023Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.10
CY2023Q4	us-gaap	Banking Regulation Capital Conservation Buffer Capital Conserved Minimum BankingRegulationCapitalConservationBufferCapitalConservedMinimum	0.025
CY2023Q4	us-gaap	Capital Capital	254030000
CY2023Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.14677
CY2023Q4	us-gaap	Excess Capital ExcessCapital	181740000
CY2023Q4	us-gaap	Banking Regulation Capital Conservation Buffer Total Risk Based Capital Actual BankingRegulationCapitalConservationBufferTotalRiskBasedCapitalActual	0.105
CY2023Q4	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	173086000
CY2023Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.10
CY2023Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	235538000
CY2023Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.13608
CY2023Q4	us-gaap	Excess Tier One Risk Based Capital ExcessTierOneRiskBasedCapital	147123000
CY2023Q4	us-gaap	Banking Regulation Capital Conservation Buffer Tier One Risk Based Capital Actual BankingRegulationCapitalConservationBufferTierOneRiskBasedCapitalActual	0.085
CY2023Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	138469000
CY2023Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.08
CY2023Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	235538000
CY2023Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.13608
CY2023Q4	bprn	Excess Common Equity Tier One Capital ExcessCommonEquityTierOneCapital	121160000
CY2023Q4	us-gaap	Banking Regulation Capital Conservation Buffer Common Equity Tier One Risk Based Capital Actual BankingRegulationCapitalConservationBufferCommonEquityTierOneRiskBasedCapitalActual	0.07
CY2023Q4	us-gaap	Common Equity Tier One Capital Required To Be Well Capitalized CommonEquityTierOneCapitalRequiredToBeWellCapitalized	112506000
CY2023Q4	us-gaap	Banking Regulation Common Equity Tier One Risk Based Capital Ratio Well Capitalized Minimum BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioWellCapitalizedMinimum	0.065
CY2023Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	235538000
CY2023Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.12289
CY2023Q4	us-gaap	Excess Tier One Leverage Capital ExcessTierOneLeverageCapital	124583000
CY2023Q4	us-gaap	Banking Regulation Leverage Buffer Actual BankingRegulationLeverageBufferActual	0.065
CY2023Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	95833000
CY2023Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.05
CY2022Q4	us-gaap	Capital Capital	233657000
CY2022Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.15309
CY2022Q4	us-gaap	Excess Capital ExcessCapital	160256000
CY2022Q4	us-gaap	Banking Regulation Capital Conservation Buffer Total Risk Based Capital Actual BankingRegulationCapitalConservationBufferTotalRiskBasedCapitalActual	0.105
CY2022Q4	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	152625000
CY2022Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.10
CY2022Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	217196000
CY2022Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.14231
CY2022Q4	us-gaap	Excess Tier One Risk Based Capital ExcessTierOneRiskBasedCapital	129731000
CY2022Q4	us-gaap	Banking Regulation Capital Conservation Buffer Tier One Risk Based Capital Actual BankingRegulationCapitalConservationBufferTierOneRiskBasedCapitalActual	0.085
CY2022Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	122100000
CY2022Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.08
CY2022Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	217196000
CY2022Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.14231
CY2022Q4	bprn	Excess Common Equity Tier One Capital ExcessCommonEquityTierOneCapital	106838000
CY2022Q4	us-gaap	Banking Regulation Capital Conservation Buffer Common Equity Tier One Risk Based Capital Actual BankingRegulationCapitalConservationBufferCommonEquityTierOneRiskBasedCapitalActual	0.07
CY2022Q4	us-gaap	Common Equity Tier One Capital Required To Be Well Capitalized CommonEquityTierOneCapitalRequiredToBeWellCapitalized	99206000
CY2022Q4	us-gaap	Banking Regulation Common Equity Tier One Risk Based Capital Ratio Well Capitalized Minimum BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioWellCapitalizedMinimum	0.065
CY2022Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	217196000
CY2022Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.13474
CY2022Q4	us-gaap	Excess Tier One Leverage Capital ExcessTierOneLeverageCapital	104775000
CY2022Q4	us-gaap	Banking Regulation Leverage Buffer Actual BankingRegulationLeverageBufferActual	0.065
CY2022Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	80596000
CY2022Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.05
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	Wolf and Company, P.C.
CY2023	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2023	dei	Auditor Firm AuditorFirmId	392

Files In Submission

Name	View Source	Status
0001193125-24-076546-index-headers.html	Edgar Link	pending
0001193125-24-076546-index.html	Edgar Link	pending
0001193125-24-076546.txt	Edgar Link	pending
0001193125-24-076546-xbrl.zip	Edgar Link	pending
bprn-20231231.xsd	Edgar Link	pending
d764933d10k.htm	Edgar Link	pending
d764933dex211.htm	Edgar Link	pending
d764933dex231.htm	Edgar Link	pending
d764933dex311.htm	Edgar Link	pending
d764933dex312.htm	Edgar Link	pending
d764933dex321.htm	Edgar Link	pending
d764933dex971.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g764933g15m88.jpg	Edgar Link	pending
g764933g79a62.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
bprn-20231231_cal.xml	Edgar Link	unprocessable
bprn-20231231_def.xml	Edgar Link	unprocessable
bprn-20231231_lab.xml	Edgar Link	unprocessable
bprn-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
d764933d10k_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BPRN
Princeton Bancorp, Inc. Stock $bprn

2024 Q1 Form 10-K Financial Statement

#000119312524076546 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BPRN Princeton Bancorp, Inc. Stock $bprn

2024 Q1 Form 10-K Financial Statement

#000119312524076546 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BPRN
Princeton Bancorp, Inc. Stock $bprn